ICE KREAM PUSH UP
A collab between Ice Kream and B Exzatik
Genetics: Lemon Cherry Gelato x Blue Nerdz
Appearance: Lemon Cherry Gelato x Blue Nerdz is an exquisite cannabis strain that showcases dense, resinous buds. The buds are typically medium to large in size and exhibit a stunning blend of colors. From vibrant lime green to deep purple, with hints of blue, this strain’s visual appeal is truly captivating. The buds are generously coated in a shimmering layer of trichomes, adding to their allure.
Aroma: Prepare to be pleasantly surprised by the enticing aroma of Lemon Cherry Gelato x Blue Nerdz. This strain releases a tantalizing fragrance that combines sweet fruity notes with a touch of earthiness. Get ready to experience a delightful blend of zesty lemon, juicy cherries, and hints of fresh berries. The aroma is both invigorating and soothing, making it hard to resist.
Flavor: Indulge your taste buds with the delectable flavors of Lemon Cherry Gelato x Blue Nerdz. This strain offers a complex taste profile that perfectly marries sweetness and tanginess. With each inhale, you’ll notice the refreshing burst of lemon and cherry flavors, followed by subtle hints of blueberries. The taste is further enhanced by a touch of herbal undertones, leaving a delicious and memorable aftertaste.
Effects: Lemon Cherry Gelato × Blue Nerdz delivers a well-balanced high that offers a combination of uplifting and relaxing effects. Initially, you’ll experience a surge of euphoria and cerebral stimulation, heightening creativity and boosting mood. As the high progresses, a soothing and tranquil relaxation sets in, allowing for a sense of calm and alleviation of tension.
Medical Benefits: This strain may provide potential benefits for both recreational and medicinal users. The uplifting effects can help alleviate symptoms of stress, anxiety, and depression, while the relaxing properties may aid in reducing physical discomfort and muscle tension.
Additionally, Lemon Cherry Gelato × Blue Nerdz is known to have appetite-stimulating effects, potentially benefiting individuals experiencing appetite loss or nausea.